Generics Bulletin is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Teva Strikes Two Settlements Over ‘Pay-For-Delay’ Agreements

Executive Summary

A California Court has secured four major settlements worth $70m with pharmaceutical companies over allegations of entering into collusive pay-for-delay agreements, including two with Teva.

You may also be interested in...



AAM Sues Over California ‘Pay-For-Delay’ Law

The AAM has filed a lawsuit seeking an injunction to prevent the implementation of Californian legislation banning ‘pay-for-delay’ deals. The law is due to come into effect in January next year.

AAM Slams California Pay-For-Delay Ban

US off-patent industry association the AAM has blasted as unconstitutional a groundbreaking California law banning so-called ‘pay-for-delay’ deals under which brand companies pay rivals to keep generics off the market.

FTC told to examine biologic pay-for-delay

The US Federal Trade Commission (FTC) should “examine whether makers of biologic medicines are using strategies like ‘pay for delay’ to hinder or delay biosimilars from entering the market”, according to an open letter from US Senators Chuck Grassley and Amy Klobuchar to the US antitrust regulator.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

SC142496

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel